Drug Safety

Romosozumab and Patients with Chronic Kidney Disease: Dr. Arthur Lau Dr. Lau discusses abstract #2730 presented at the 2019 ACR/ARP annual meeting in Atlanta.

Inflammatory Arthritis Persists After Immunotherapy Cessation: Dr. David Liew Dr. Liew discusses abstract #1808 Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis Persists After Immunotherapy Cessation presented at the 2019 ACR/ARP Annual Meeting in Atlanta.

Panel Presentation: Rheumatoid Arthritis Drs. Jack Cush, Arthur Kavanaugh and Jonathan Kay discuss several rheumatoid arthritis studies presented at the 2019 ACR/ARP Annual Meeting in Atlanta. Abstracts discussed include abstract #1342, #1350, #1160, and more.

Safety of Methotrexate (The CIRT Trial): Dr. Jack Cush Dr. Cush discusses abstract #1890 on the CIRT trial as presented at the 2019 ACR/ARP annual meeting in Atlanta.

Panel Presentation: What's New in iRAEs Drs. Laura Cappelli, Len Calabrese and Cassandra Calabrese discuss iRAE studies presented at the 2019 ACR/ARP annual meeting in Atlanta.

FDA Update: Dr. Arthur Kavanaugh Dr. Kavanaugh gives an overview of the FDA Update session presented at the 2019 ACR/ARP Annual Meeting.

Fibromyalgia Treatments: Dr. Philip Robinson Dr. Robinson highlights a 2019 ACR annual meeting session on fibromyalgia.

Antimalarials in RA: Dr. Janet Pope Dr. Janet Pope discusses two abstracts - #1891 and #896 - regarding hydroxychloroquine in RA at the 2019 ACR/ARP annual meeting in Atlanta.

Infection Prevention and Immunosuppression: Dr. Cassandra Calabrese Dr. Cassandra Calabrese gives an overview of a talk on infection prevention, vaccines and immunosuppression at the 2019 ACR/ARP annual meeting in Atlanta.